Relying on the fully equipped analysis and detection technology platform, Huizhi Taikang has accumulated rich experience in drug standard establishment and quality control in drug content analysis, impurity analysis and stability research. Huizhi Taikang promises to carry out the entrusted research work for customers in full compliance with the guidance requirements of the International Coordinating Organization (ICH), the standard requirements of the Chinese Pharmacopoeia and the GLP/cGMP management requirements of domestic and foreign pharmaceutical regulatory agencies.